The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Peptide-based cancer therapy: Opportunity and challenge
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Smith, G. P. (1985) · Science · doi:10.1126/science.4001944 · Cited by 4,143
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
The Future of Peptide‐based Drugs
Craik, D. J., Fairlie, D. P., Liras, S., & Price, D. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12055 · Cited by 1,979
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P., Mitra, S. S., Wang, J., Contreras-Trujillo, H., Martin, R., Cohen, J. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121623109 · Cited by 1,666
Synthetic therapeutic peptides: science and market
Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.009 · Cited by 1,476
Cancer despite immunosurveillance: immunoselection and immunosubversion
Zitvogel, L., Tesniere, A., & Kroemer, G. (2006) · Nature reviews. Immunology · doi:10.1038/nri1936 · Cited by 1,324 · cited 1×
“Tumor cells share many characteristics, such as enabling replicative immortality, evading cell death, escaping the host immune system, and others [2–5].”
BackgroundAminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 966
Aggarwal, B. B., Gupta, S. C., & Kim, J. H. (2012) · Blood · doi:10.1182/blood-2011-04-325225 · Cited by 877
Fernald, K., & Kurokawa, M. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.07.006 · Cited by 579
Tumor targeting with a selective gelatinase inhibitor
Koivunen, E., Arap, W., Valtanen, H., Rainisalo, A., Medina, O. P., Heikkilä, P., Kantor, C., Gahmberg, C. G., Salo, T., Konttinen, Y. T., et al. (1999) · Nature Biotechnology · doi:10.1038/11703 · Cited by 567
Angiogenesis Inhibitors: Current Strategies and Future Prospects
Cook, K. M., & Figg, W. D. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20075 · Cited by 474
Temming, K., Schiffelers, R. M., Molema, G., & Kok, R. J. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.10.002 · Cited by 467
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K., Wrasidlo, W., & Cheresh, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803728105 · Cited by 455
Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment
Mader, J. S., & Hoskin, D. W. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.8.933 · Cited by 430
Antiviral and antitumor peptides from insects
Chernysh, S., Kim, S. I., Bekker, G., Pleskach, V. A., Filatova, N. A., Anikin, V. B., Platonov, V. G., & Bulet, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192301899 · Cited by 375
Padanilam, B. J. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00284.2002 · Cited by 372
Signaling Pathways in Cancer and Embryonic Stem Cells
Dreesen, O., & Brivanlou, A. H. (2007) · Stem Cell Reviews · doi:10.1007/s12015-007-0004-8 · Cited by 357
Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel
Danhier, F., Vroman, B., Lecouturier, N., Crokart, N., Pourcelle, V., Freichels, H., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.011 · Cited by 335
Peptides and Peptide Hormones for Molecular Imaging and Disease Diagnosis
Lee, S., Xie, J., & Chen, X. (2010) · Chemical Reviews · doi:10.1021/cr900361p · Cited by 324
Slansky, J. E., Rattis, F. M., Boyd, L. F., Fahmy, T., Jaffee, E. M., Schneck, J. P., Margulies, D. H., & Pardoll, D. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00052-2 · Cited by 309
Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
Pastorino, F., Brignole, C., Marimpietri, D., Cilli, M., Gambini, C., Ribatti, D., Longhi, R., Allen, T. M., Corti, A., & Ponzoni, M. (2003) · PubMed · Cited by 296
Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis
Binetruy-Tournaire, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1525 · Cited by 295
Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis
Lieu, C., Heymach, J., Overman, M., Tran, H., & Kopetz, S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0659 · Cited by 286
Inhibition of melanoma tumor growth in vivo by survivin targeting
Grossman, D., Kim, P. J., Schechner, J. S., & Altieri, D. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.635 · Cited by 286
Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells
Laakkonen, P., Åkerman, M. E., Biliran, H., Yang, M., Ferrer, F., Karpanen, T., Hoffman, R. M., & Ruoslahti, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403317101 · Cited by 275
Kummar, S., Chen, H. X., Wright, J., Holbeck, S., Millin, M. D., Tomaszewski, J., Zweibel, J., Collins, J., & Doroshow, J. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3216 · Cited by 247
Antiangiogenic therapies for high-grade glioma
Norden, A. D., Drappatz, J., & Wen, P. Y. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.159 · Cited by 245
Peptides in cancer nanomedicine: Drug carriers, targeting ligands and protease substrates
Zhang, X.-X., Eden, H. S., & Chen, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.023 · Cited by 243
Jain, M. V., Paczulla, A. M., Klonisch, T., Dimgba, F. N., Rao, S. B., Roberg, K., Schweizer, F., Lengerke, C., Davoodpour, P., Palicharla, V. R., et al. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12001 · Cited by 240
Anticancer efficacy of Magainin2 and analogue peptides.
Baker, M. A., Maloy, W. L., Zasloff, M., & Jacob, L. S. (1993) · PubMed · Cited by 236
Antitumor Activity of the Antimicrobial Peptide Magainin II against Bladder Cancer Cell Lines
Lehmann, J., Retz, M., Sidhu, S. S., Suttmann, H., Sell, M., Paulsen, F., Harder, J., Unteregger, G., & Stöckle, M. (2006) · European Urology · doi:10.1016/j.eururo.2005.12.043 · Cited by 228
Theodoropoulou, M., Zhang, J., Laupheimer, S., Paez-Pereda, M., Erneux, C., Florio, T., Pagotto, U., & Stalla, G. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1189 · Cited by 216
The Chemical Versatility of Natural-Product Assembly Lines
Walsh, C. T. (2008) · Accounts of Chemical Research · doi:10.1021/ar7000414 · Cited by 211
Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
Devaud, C., John, L. B., Westwood, J. A., Darcy, P. K., & Kershaw, M. H. (2013) · OncoImmunology · doi:10.4161/onci.25961 · Cited by 207
Suárez, Y., González, L. E., Cuadrado, A., Berciano, M., Lafarga, M., & Múñoz, A. (2003) · PubMed · Cited by 191
Target-specific delivery of peptide-based probes for PET imaging
Chen, K., & Conti, P. S. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.004 · Cited by 190
Structure-Activity Relationships of Linear and Cyclic Peptides Containing the NGR Tumor-homing Motif
Colombo, G., Curnis, F., De Mori, G. M. S., Gasparri, A., Longoni, C., Sacchi, A., Longhi, R., & Corti, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207500200 · Cited by 188
Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide
Lee, H. S., Park, C. B., Kim, J. M., Jang, S. A., Park, I. Y., Kim, M. S., Cho, J. H., & Kim, S. C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.041 · Cited by 188
Yu, D.-H., Lu, Q., Xie, J., Fang, C., & Chen, H.-Z. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.047 · Cited by 175
Fernandez-Patron, C., Stewart, K. G., Zhang, Y., Koivunen, E., Radomski, M. W., & Davidge, S. T. (2000) · Circulation Research · doi:10.1161/01.res.87.8.670 · Cited by 175
Targeting apoptotic and autophagic pathways for cancer therapeutics
Liu, J.-J., Lin, M., Yu, J.-Y., Liu, B., & Bao, J.-K. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.10.001 · Cited by 170
Selective targeting of cancer cells using synthetic peptides
Shadidi, M., & Sioud, M. (2003) · Drug Resistance Updates · doi:10.1016/j.drup.2003.11.002 · Cited by 170
Starzec, A., Vassy, R., Martin, A., Lecouvey, M., Di Benedetto, M., Crépin, M., & Perret, G. Y. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.08.005 · Cited by 167
Anticancer activity of hydrophobic peptides from soy proteins
Kim, S. E., Kim, H. H., Kim, J. Y., Kang, Y. I., Woo, H. J., & Lee, H. J. (2000) · BioFactors · doi:10.1002/biof.5520120124 · Cited by 162
Lunasin, a novel seed peptide for cancer prevention
Hernández‐Ledesma, B., Hsieh, C. C., & de Lumen, B. O. (2008) · Peptides · doi:10.1016/j.peptides.2008.11.002 · Cited by 161
Perea, S. E., Reyes, O., Puchades, Y., Mendoza, O., Vispo, N. S., Torréns, I., Santos, A., Silva, R., Acevedo, B. E., López, E., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2086 · Cited by 159
Targeting tumors with peptides from natural sources
Bhutia, S. K., & Maiti, T. K. (2008) · Trends in biotechnology · doi:10.1016/j.tibtech.2008.01.002 · Cited by 157
Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome
Negussie, A. H., Miller, J. L., Reddy, G., Drake, S. K., Wood, B. J., & Dreher, M. R. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.031 · Cited by 156
Risso, A., Braidot, E., Sordano, M. C., Vianello, A., Macrì, F., Skerlavaj, B., Zanetti, M., Gennaro, R., & Bernardi, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1926-1935.2002 · Cited by 156
Bono, F., Smet, F. D., Herbert, C., Bock, K. D., Γεωργιάδου, Μ., Fons, P., Tjwa, M., Alcouffe, C., Ny, A., Bianciotto, M., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.019 · Cited by 154
iRGD-coupled responsive fluorescent nanogel for targeted drug delivery
Su, S., Wang, H., Liu, M., Wu, Y. F., & Nie, G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.083 · Cited by 152
Discovery of natural product anticancer agents from biodiverse organisms.
Kinghorn, A. D., Chin, Y., & Swanson, S. M. (2009) · PubMed · Cited by 151
Cao, Q., & Lin, Z. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.07.017 · Cited by 150
Okumura, K., Itoh, A., Isogai, E., Hirose, K., Hosokawa, Y., Abiko, Y., Shibata, T., Hirata, M., & Isogai, H. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.04.006 · Cited by 147
Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel
Eldar-Boock, A., Miller, K., Sanchis, J., Lupu, R., Vicent, M., & Satchi-Fainaro, R. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.073 · Cited by 120
IgA EGFR antibodies mediate tumour killing in vivo
Boross, P., Lohse, S., Nederend, M., Jansen, J. H. M., van Tetering, G., Dechant, M., Peipp, M., Royle, L., Liew, L. P., Boon, L., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201929 · Cited by 118
Phage Display of Combinatorial Peptide Libraries: Application to Antiviral Research
Castel, G., Chtéoui, M., Heyd, B., & Tordo, N. (2011) · Molecules · doi:10.3390/molecules16053499 · Cited by 117
Lei, H., An, P., Shumei, S., Xiaoying, L., Luowen, H., Jian, W., Lin, M., Meisheng, L., Junshan, Y., & Chengchao, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203103200 · Cited by 116
Zhao, B., Zhao, Y., Huang, Y., Luo, L.-M., Song, P., Wang, X., Chen, S., Yu, K., Zhang, X., & Zhang, Q. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.078 · Cited by 116
Chen, J., Lin, W.-J., & Lin, T.-L. (2009) · Peptides · doi:10.1016/j.peptides.2009.06.009 · Cited by 115
TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis
Yang, W., Luo, D., Wang, S., Wang, R., Chen, R., Liu, Y., Zhu, T., Ma, X., Liu, R., Xu, G., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0233 · Cited by 115
Ogawa, C., Liu, Y.-J., & Kobayashi, K. S. (2011) · Current Bioactive Compounds · doi:10.2174/157340711796817913 · Cited by 112
Wang, K., Yan, J., Zhang, B., Song, J., Jia, P.-F., & Wang, R. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.12.027 · Cited by 110
Ferrante, E., Pellegrini, C., Bondioni, S., et al. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01191 · Cited by 109
Bae, D., Kim, T., Li, G., Yoon, W.-H., & Chae, C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1564 · Cited by 108
Amit, D., & Hochberg, A. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-134 · Cited by 104
Luo, L.-M., Huang, Y., Zhao, B., Zhao, X. S., Duan, Y., Du, R., Yu, K., Song, P., Zhao, Y., Zhang, X., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.029 · Cited by 103
Kim, S., Kim, S. S., Bang, Y., Kim, S., & Lee, B. J. (2003) · Peptides · doi:10.1016/s0196-9781(03)00194-3 · Cited by 102
Perea, S. E., Reyes, O., Baladrón, I., Perera, Y., Fariña, H. G., Gil, J., Rodríguez, A., Bacardí, D., Marcelo, J., Cosme, K., et al. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9814-5 · Cited by 101
Angiotensin-(1-7) Reduces Fibrosis in Orthotopic Breast Tumors
Cook, K. L., Metheny‐Barlow, L. J., Tallant, E. A., & Gallagher, P. E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1136 · Cited by 98
Yap, R. L., Veliceasa, D., Emmenegger, U., Kerbel, R. S., McKay, L. M., Henkin, J., & Volpert, O. V. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0621 · Cited by 97
Didemnins, tamandarins and related natural products
Lee, J., Currano, J. N., Carroll, P. J., & Joullié, M. M. (2012) · Natural Product Reports · doi:10.1039/c2np00065b · Cited by 95
IL-27 in tumor immunity and immunotherapy
Murugaiyan, G., & Saha, B. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.12.002 · Cited by 95
Li, J., Zhang, J., He, H., Ma, Z., Nie, Z.-K., Wang, Z., & Xu, X.-G. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.09.038 · Cited by 93
Tournaire, R., Simon, M., le Noble, F. A. C., Eichmann, A., England, P., & Pouysségur, J. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400100 · Cited by 91
Madden, T. L., Tran, H. T., Beck, D., Huie, R., Newman, R. A., Pusztai, L., Wright, J. R., & Abbruzzese, J. L. (2000) · PubMed · Cited by 90
Su, J.-L., Lai, K.-P., Chen, C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0188 · Cited by 89
Keenamide A, a Bioactive Cyclic Peptide from the Marine Mollusk Pleurobranchus forskalii
Wesson, K. J., & Hamann, M. T. (1996) · Journal of Natural Products · doi:10.1021/np960153t · Cited by 87
Therapeutic application of monoclonal antibodies in cancer: advances and challenges
Modjtahedi, H., Ali, S., & Essapen, S. (2012) · British Medical Bulletin · doi:10.1093/bmb/lds032 · Cited by 82
Targeted Drug Delivery to Hepatocarcinoma In vivo by Phage-Displayed Specific Binding Peptide
Du, B., Han, H., Wang, Z., Kuang, L., Wang, L., Yu, L., Wu, M., Zhou, Z., & Qian, M. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0339 · Cited by 80
Structure and function of a custom anticancer peptide, CB1a
Wu, J.-M., Jan, P.-S., Yu, H.-C., Haung, H.-Y., Fang, H., Chang, Y., Cheng, J.-W., & Chen, H. M. (2009) · Peptides · doi:10.1016/j.peptides.2009.02.004 · Cited by 79
Cao, Q., Li, Z., Chen, K., Wu, Z., He, L., Neamati, N., & Chen, X. S. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0744-y · Cited by 79
The combined effects of antibacterial peptide cecropin A and anti-cancer agents on leukemia cells.
Hui, L., Leung, K., & Chen, H. M. (2002) · PubMed · Cited by 77
Yi, Z., Cho, S., Zhao, H., Wu, Y., Luo, J., Li, D., Yi, T., Xu, X., Wu, Z., & Liu, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.24027 · Cited by 77
Bevacizumab: current updates in treatment
Meter, M. E. M. V., & Kim, E. S. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32833edc0c · Cited by 77
Design of a Partial Peptide Mimetic of Anginex with Antiangiogenic and Anticancer Activity
Mayo, K. H., Dings, R. P. M., Flader, C., Nesmelova, I. V., Hargittai, B., van der Schaft, D. W. J., van Eijk, L. I., Walek, D., Haseman, J., Hoye, T. R., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308608200 · Cited by 76
Karagiannis, E. D., & Popel, A. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803241105 · Cited by 76
A novel hybrid peptide targeting EGFR-expressing cancers
Kohno, M., Horibe, T., Haramoto, M., Yano, Y., Ohara, K., Nakajima, O., Matsuzaki, K., & Kawakami, K. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.10.021 · Cited by 73
An, P., Lei, H., Zhang, J., Shumei, S., Luowen, H., Jin, G., Liu, X., Wu, J. L., Meng, L., Meisheng, L., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20214 · Cited by 73
Yang, X., Zhang, Y., Yang, Y., Lim, S., Cao, Z., Rak, J. W., & Cao, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309629110 · Cited by 72
Greenaway, J. B., Henkin, J., Lawler, J., Moorehead, R. A., & Petrik, J. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0864 · Cited by 71
Human α-defensin-1 inhibits growth of human lung adenocarcinoma xenograft in nude mice
Xu, N., Wang, Y., Pan, W., Xiao, B., Wen, Y., Chen, X., Chen, L., Deng, H., You, J., Kan, B., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0010 · Cited by 71
Self-citationWang, C., Zhou, Y., Li, S., Li, H., Tian, L., Wang, H., & Shang, D. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.03.016 · Cited by 70
Kang, J., Zhao, G., Lin, T., Tang, S., Xu, G., Hu, S., Bi, Q., Guo, C., Sun, L., Han, S., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.06.016 · Cited by 68
Fang, X., Chen, W., Fan, J.-T., Song, R., Wang, L., Gu, Y.-H., Zeng, G., Shen, Y., Wu, X.-F., Tan, N. H., et al. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.12.010 · Cited by 67
Epinecidin-1 peptide induces apoptosis which enhances antitumor effects in human leukemia U937 cells
Chen, J., Lin, W., Wu, J., Her, G. M., & Hui, C. (2009) · Peptides · doi:10.1016/j.peptides.2009.08.019 · Cited by 67
Activation of the Proapoptotic Death Receptor DR5 by Oligomeric Peptide and Antibody Agonists
Li, B., Russell, S. J., Compaan, D. M., Tótpál, K., Marsters, S. A., Ashkenazi, A., Cochran, A. G., Hymowitz, S. G., & Sidhu, S. S. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.06.042 · Cited by 65
Intratumoral Expression of Mature Human Neutrophil Peptide-1 Mediates Antitumor Immunity in Mice
Wang, Y., Li, D., Shi, H., Wen, Y., Yang, L., Xu, N., Chen, X., Chen, X., Chen, P., Li, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0484 · Cited by 65
Self-citationHuh, J., Kang, J. W., Nam, D., Baek, Y.-H., Choi, D., Park, D., & Lee, J.-D. (2012) · Journal of Natural Products · doi:10.1021/np300446c · Cited by 63
Song, R., Wei, R., Zhang, B., et al. (2011) · Marine Drugs · doi:10.3390/md9061142 · Cited by 63
A novel mouse CD133 binding-peptide screened by phage display inhibits cancer cell motility in vitro
Sun, J., Zhang, C., Liu, G., Liu, H., Zhou, C.-P., Lu, Y., Zhou, C., Li, Y., & Li, X. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9440-6 · Cited by 58
Self-citationSelection and Characterization of Tenascin C Targeting Peptide
Kim, M. Y., Kim, O. R., Choi, Y. S., Lee, H., Park, K., Lee, C., Kang, K. W., & Jeong-Yu, S. (2011) · Molecules and Cells · doi:10.1007/s10059-012-2214-4 · Cited by 58
Chan, Y. R., Zanetti, M., Gennaro, R., & Gallo, R. L. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01231.x · Cited by 57
Ohtake, T., Fujimoto, Y., Ikuta, K., Saito, H., Ohhira, M., Ōno, M., & Kohgo, Y. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690707 · Cited by 57
Targeting angiogenesis in ovarian cancer
Schmitt, J., & Matei, D. E. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.06.004 · Cited by 53
Ishikawa, D., Kikkawa, H., Ogino, K., Hirabayashi, Y., Oku, N., & Taki, T. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01511-7 · Cited by 53
Rajanbabu, V., Pan, C., Lee, S.-C., Lin, W.-J., Lin, C.-C., Li, C., & Chen, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.137935 · Cited by 51
Lee, E., Koskimaki, J. E., Pandey, N. B., & Popel, A. S. (2013) · Neoplasia · doi:10.1593/neo.121638 · Cited by 50
Peng, X., Li, Y., Yang, L., Mao, Y.-Q., Yang, H., Liu, J., Zhang, D., Chen, L.-J., & Wei, Y.-Q. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-46 · Cited by 50
Self-citationEvaluation of 64Cu Labeled GX1: A Phage Display Peptide Probe for PET Imaging of Tumor Vasculature
Chen, K., Sun, X., Niu, G., Ma, Y., Yap, L.-P., Hui, X., Wu, K., Fan, D., Conti, P. S., & Chen, X. S. (2011) · Molecular Imaging and Biology · doi:10.1007/s11307-011-0479-1 · Cited by 50
Self-citationDings, R. P. M., Laar, E. S. V., Webber, J., Zhang, Y., Griffin, R. J., Waters, S. J., MacDonald, J. R., & Mayo, K. H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.048 · Cited by 48
Kang, T. H., Mao, C.-P., He, L., Tsai, Y.-C., Liu, K., La, V., Wu, T. ‐., & Hung, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035141 · Cited by 45
Han, Y., Liu, H., Han, D., Zong, X., Zhang, S., & Chen, Y. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.008 · Cited by 42
Lin, M., Lin, S., Chen, J., Hui, C., & Chen, J.-Y. (2010) · Peptides · doi:10.1016/j.peptides.2010.02.023 · Cited by 42
Takeuchi, H., Ara, G., Sausville, E. A., & Teicher, B. A. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050850 · Cited by 38
Wu, X., Huang, H., Wang, C., Lin, S., Huang, Y., Wang, Y., Liang, G., Yan, Q., Xiao, J., Wu, J., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1312 · Cited by 38
Wang, W., Chen, X., Li, T., Li, Y., Wang, R., He, D. N., Luo, W., Li, X., & Wu, X. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.02.007 · Cited by 37
Self-citationTotal Synthesis and Biological Evaluation of Tamandarin B Analogues
Adrio, J., Cuevas, C., Manzanares, I., & Joullié, M. M. (2007) · The Journal of Organic Chemistry · doi:10.1021/jo070412r · Cited by 37
Paduano, F., Ortuso, F., Campiglia, P., Raso, C., Iaccino, E., Gaspari, M., Gaudio, E., Mangone, G., Carotenuto, A., Bilotta, A., et al. (2012) · ACS Chemical Biology · doi:10.1021/cb300281t · Cited by 36
Horibe, T., Torisawa, A., Kohno, M., & Kawakami, K. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-59 · Cited by 35
Tada, N., Horibe, T., Haramoto, M., Ohara, K., Kohno, M., & Kawakami, K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.030 · Cited by 34
Suppression of tumor growth by novel peptides homing to tumor‐derived new blood vessels
Asai, T., Nagatsuka, M., Kuromi, K., Yamakawa, S., Kurohane, K., Ogino, K., Tanaka, M., Taki, T., & Oku, N. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03265-3 · Cited by 33
Effect of rapeseed peptide on DNA damage and apoptosis in Hela cells
Xue, Z., Liu, Z., Wu, M., Zhuang, S., & Yu, W. (2009) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2009.06.013 · Cited by 33
Fan, Y., Chang, H., Yu, Y., Liu, J., Li, Z., Yang, D.-J., & Wang, R. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.07.004 · Cited by 33
MMP-2 Selectivity in Hydroxamate-Type Inhibitors
Serra, P., Bruczko-Goralewska, M., Zapico, J. M., et al. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799320628 · Cited by 33
Hodous, B. L., Geuns-Meyer, S. D., Hughes, P. E., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.02.067 · Cited by 32
Lin, M., Pan, C., Hui, C., Chen, J., & Wu, J.-L. (2012) · Peptides · doi:10.1016/j.peptides.2012.11.010 · Cited by 32
Guo, C., Liu, K., Luo, H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017734 · Cited by 30
Iwamoto, Y., Fujita, Y., & Sugioka, Y. (1992) · Clinical & Experimental Metastasis · doi:10.1007/bf00132750 · Cited by 22
The antibacterial peptide ABP-CM4: the current state of its production and applications
Li, J. F., Zhang, J., Xu, X. Z., Han, Y., Cui, X., Chen, Y. Q., & Zhang, S. Q. (2011) · Amino Acids · doi:10.1007/s00726-011-0982-3 · Cited by 17
Roşca, E., Koskimaki, J. E., Pandey, N. B., Wolff, A. C., & Popel, A. S. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.9.17677 · Cited by 15
Effect of bovine lactoferricin on DNA methyltransferase 1 levels in Jurkat T-leukemia cells
Zhang, T.-N., & Liu, N. (2010) · Journal of Dairy Science · doi:10.3168/jds.2009-3024 · Cited by 14
A potential antitumor peptide therapeutic derived from antineoplastic urinary protein
Hehir, K. M., Baguisi, A. B., Pennington, S. E., Bates, J. M., & DiTullio, P. (2004) · Peptides · doi:10.1016/j.peptides.2004.02.003 · Cited by 8
Cited by
Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields
Huan, Y., Kong, Q., Mou, H., & Yi, H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.582779 · Cited by 1,595
Self‐Assembled Peptide‐Based Nanomaterials for Biomedical Imaging and Therapy
Qi, G., Gao, Y., Wang, L., & Wang, H. (2018) · Advanced Materials · doi:10.1002/adma.201703444 · Cited by 527
Self-citationEvaluation of the use of therapeutic peptides for cancer treatment
Marqus, S., Pirogova, E., & Piva, T. J. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0328-x · Cited by 512
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Zheng, W., Hu, Y., & Shi, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02107-5 · Cited by 449
Peptides with Dual Antimicrobial and Anticancer Activities
Felício, M. R., Silva, O. N., Gonçalves, S., Santos, N. C., & Franco, O. L. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00005 · Cited by 393
Metadata
- Authors
- Wu, D., Gao, Y., Qi, Y., Chen, L., Ma, Y., & Li, Y.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 351
- Issue
- 1
- Pages
- 13-22
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2136007332
- Cited by
- 306
- References
- 138
- FWCI
- 13.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.